Methods of preparing immune globin and uses thereof
The present invention provides for methods of preparing purified immune globulins, immune globulin compositions, and methods of treating allergies and conditions by administering immune globulin compositions. For example, the present invention provides for purified IgG4 that is essentially free of other IgG subtypes that can be used to treat allergies and other conditions.
1. A method of treating a patient envenomated by an insect sting comprising:
administering a pharmaceutical composition comprising between 50-1000 milligrams of an IgG4 preparation that is essentially free of other IgG subtypes to a patient envenomated by an insect sting, wherein the IgG4 preparation has no visible signs of protein degradation.
2. The method of claim 1 , wherein said insect is selected from the group consisting of flying insects, bees, honey bees, Africanized “killer” bees, wasps, hornets, yellow jackets, and hymenoptera.
3. The method of claim 1 , wherein said pharmaceutical composition is administered prior to said patient being envenomated.
4. The method of claim 1 , wherein said pharmaceutical composition is administered after said patient is envenomated.
5. The method of claim 1 , wherein said pharmaceutical composition is administered to the patient by injection.
6. The method of claim 1 , wherein said pharmaceutical composition is administered to the patient orally.
7. The method of claim 1 , wherein said pharmaceutical composition is administered to the patient by inhalation.
8. The method of claim 1 , wherein said pharmaceutical composition is administered to the patient transdermally.
9. The method of claim 1 , wherein the IgG4 preparation has less than 3% each of IgG1, and IgG2 subtypes.
10. The method of claim 1 , wherein the IgG4 preparation consists essentially of IgG4.
11. A method of treating a patient envenomated by an insect sting comprising:
administering a pharmaceutical composition comprising a therapeutic amount of an IgG4 preparation that is essentially free of other IgG subtypes to a patient envenomated by an insect sting, wherein the IgG4 preparation has no visible signs of protein degradation and wherein the pharmaceutical composition is administered to the patient at four month intervals.
12. A method of treating a patient envenomated by an insect sting comprising:
administering a pharmaceutical composition comprising a therapeutic amount of an IgG4 preparation that is essentially free of other IgG subtypes to a patient envenomated by an insect sting, wherein the IgG4 preparation has no visible signs of protein degradation, and wherein, after administration of the pharmaceutical composition, the patient is able to withstand a second dose of bee venom that is 100,000 times larger than a first dose of bee venom that causes anaphylaxis before administration of the pharmaceutical composition.
13. The method of claim 11 , or claim 12 , wherein the therapeutic amount of IgG4 is 50-1000 milligrams.
14. The method of claim 12 , wherein the second dose of bee venom is administered four months after the first dose.